Key Highlights
- Samsung’s digital radiography products, GM85 and GC85A Vision, are enhanced with Lunit INSIGHT CXR and Lunit Insight CXR Triage, improving chest X-ray screenings.
- The integration allows radiologists to prioritize patients with suspected abnormalities, streamlining the diagnosis process and enhancing patient care.
- Lunit’s AI-powered solutions are commercially available on Samsung digital radiology products as of Q1 2024, targeting a global market, including North America, Europe, the Middle East, South America, and Southeast Asia.
Source: Business Wire
Notable Quotes
- “As advanced technologies deliver improved patient outcomes and cost savings in healthcare, our digital radiography flagship products GM85 and GC85A Vision are at the forefront of that innovation.” – David Legg, Head at Boston Imaging
- “Chest X-rays are still today the most requested exam in radiography. By partnering with Lunit, our Samsung digital radiology products will now have computer-assisted triage and notification software that analyzes adult chest X-ray images for the presence of suspected pleural effusion or pneumothorax.” – Eric Sumner, Head at Digital Radiography
SoH's Take
The collaboration between Samsung and Lunit Inc. marks a significant leap in the field of digital radiography, combining Samsung’s innovative imaging technology with Lunit’s advanced AI diagnostics. This partnership is set to redefine patient care standards, streamlining workflows, and enabling quicker, more accurate diagnoses. With the commercial availability of these AI-enhanced products, Samsung is not only solidifying its position as a leader in medical imaging but also demonstrating a strong commitment to global healthcare advancements. This is indicative of a broader trend in healthcare where technology and AI are being leveraged to enhance patient outcomes and operational efficiencies significantly.
